ORIC Pharmaceuticals (NASDAQ:ORIC) Rating Reiterated by Cantor Fitzgerald
Cantor Fitzgerald reiterated their overweight rating on shares of ORIC Pharmaceuticals (NASDAQ:ORIC – Free Report) in a research report released on Thursday morning, Benzinga reports. Several other analysts have also commented on the stock. HC Wainwright raised their price objective on shares of ORIC Pharmaceuticals from $15.00 to $21.00 and gave the stock a buy […]
More Stories
Kentucky First Federal Bancorp (NASDAQ:KFFB) Short Interest Update
Kentucky First Federal Bancorp (NASDAQ:KFFB – Get Free Report) saw a significant decline in short interest in the month of...
Mitsubishi Motors Co. (OTCMKTS:MMTOF) Short Interest Down 17.6% in September
Mitsubishi Motors Co. (OTCMKTS:MMTOF – Get Free Report) was the target of a significant decline in short interest during the...
Short Interest in AltaGas Ltd. (OTCMKTS:ATGFF) Rises By 23.2%
AltaGas Ltd. (OTCMKTS:ATGFF – Get Free Report) was the recipient of a large increase in short interest during the month...
Ald S.A. (OTCMKTS:ALLDF) Short Interest Up 23.3% in September
Ald S.A. (OTCMKTS:ALLDF – Get Free Report) was the recipient of a significant growth in short interest during the month...
The Old Guard 2 Release Date, Returning Cast, and New Additions
Fans have been waiting patiently for the sequel to 2020’s The Old Guard, which was a smash hit for streaming...
Premier, Inc. (NASDAQ:PINC) Given Average Recommendation of “Hold” by Brokerages
Premier, Inc. (NASDAQ:PINC – Get Free Report) has earned a consensus recommendation of “Hold” from the nine research firms that...